|
|
 |
 |
 |
|
H. Jack West, MD
Medical Director
Thoracic Oncology Program Swedish Cancer Institute
President & CEO, GRACE
|
Matthew Gubens, MD
Thoracic Oncologist Thoracic Surgery and Oncology Clinic UCSF Helen Diller Family Comprehensive Cancer Center
|
Jyoti D. Patel, MD
Director Thoracic Oncology
University of Chicago Medicine
|
|
Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer. Â In this roundtable video, the doctors discuss What is the role for Immunotherapy in Relapsed Small Cell Lung Cancer after ASCO 2017?
|
 Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
   |
||
 |
  |  |
 Â Â |
    |       |
Â
|
|
|
|
H. Jack West, MD
Medical Director
Thoracic Oncology Program Swedish Cancer Institute
President & CEO, GRACE
|
Matthew Gubens, MD
Thoracic Oncologist Thoracic Surgery and Oncology Clinic UCSF Helen Diller Family Comprehensive Cancer Center
|
Jyoti D. Patel, MD
Director Thoracic Oncology
University of Chicago Medicine
|
|
Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer. Â In this roundtable video, the doctors discuss Emerging Options for Malignant Pleural Mesothelioma.
|
 Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
| Â Â |
||
|
  | |
| Â Â |
    |      |
Â
|
|
|
|
H. Jack West, MD
Medical Director
Thoracic Oncology Program Swedish Cancer Institute
President & CEO, GRACE
|
Matthew Gubens, MD
Thoracic Oncologist Thoracic Surgery and Oncology Clinic UCSF Helen Diller Family Comprehensive Cancer Center
|
Jyoti D. Patel, MD
Director Thoracic Oncology
University of Chicago Medicine
|
|
Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer. Â In this roundtable video, the doctors discuss Continuing Immunotherapy Beyond Progression.
|
 Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
| Â Â |
||
|
  | |
| Â Â |
    |      |
Â
H. Jack West, MD
President & CEO, GRACE
We are pleased to have GRACE’s Jack West, MD, Medical Director, Thoracic Oncology Program, Swedish Cancer Institute in Seattle, Washington, and President and CEO of GRACE bring 2017 updates to our Lung Cancer Video Library. Â
In this latest video, Dr. West discusses exciting new advances in SCLC – Â Novel Therapies In Small Cell Lung Cancer (SCLC): Lurbinectedin. Â
Please feel free to offer comments and raise questions in our Discussion Forums.
          
Â
Â
     
     
    Â
Â
 ÂÂ
Â
 Â
|
|
|
|
H. Jack West, MD
Medical Director
Thoracic Oncology Program Swedish Cancer Institute
President & CEO, GRACE
|
Matthew Gubens, MD
Thoracic Oncologist Thoracic Surgery and Oncology Clinic UCSF Helen Diller Family Comprehensive Cancer Center
|
Jyoti D. Patel, MD
Director Thoracic Oncology
University of Chicago Medicine
|
|
Drs. H. Jack West, Medical Director of the Thoracic Oncology Program at Swedish Cancer Institute in Seattle, Washington and President and CEO of GRACE, Matthew Gubens, Thoracic Oncologist at the Thoracic Surgery and Oncology Clinic of the UCSF Helen Diller Family Comprehensive Center in San Francisco, California, and Jyoti Patel, Director of Thoracic Oncology at University of Chicago Medicine gathered post meeting to discuss new information from ASCO 2017 regarding lung cancer. Â In this roundtable video, the doctors discuss What is PFS2 in Advanced NSCLC, and Should we Care? Unique Analysis of the KEYNOTE-024 Trial.
|
 Please feel free to offer comments and raise questions in our Discussion Forums.
GRACE would like to thank the following sponsors for their support of this program
| Â Â |
||
|
  | |
| Â Â |
    |      |
Â
| Follow us on... |      |
||
Copyright ©2017 GRACE - All Rights Reserved |
|||
Recent Comments